Laws, Protections and Public Policy
Our blog features information and personal perspectives on topics of interest to the hereditary cancer community.
June 14, 2023
Reflections on 10 Years Without Gene Patents
Posted in...:
Laws, Protections And Public Policy
Tags:
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Advocacy ,
FORCE
May 01, 2023
What is Legal about Cancer?
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
June 15, 2022
Advocacy Spotlight: Increasing Our Focus on State Level Issues
Posted in:
Laws, Protections And Public Policy ,
Partnerships
Tags:
Cancer Advocacy ,
Patient Advocacy ,
Cancer Policy
February 19, 2020
New Medicare Genetic Testing Policy: What Does It Mean to Me?
Posted in:
Laws, Protections And Public Policy
Tags:
Hereditary Cancer ,
Genetic Testing ,
Medicare ,
Multigenetesting ,
Tumorbiomarker
July 11, 2019
Protect Yourself, Your Friends and Family from Fraudulent Genetic Testing
Posted in:
Laws, Protections And Public Policy
Tags:
Hereditary Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2
May 30, 2019
Alert: Cancer Genetic Testing Should Be Performed in the Health Care Setting
Posted in:
Laws, Protections And Public Policy ,
Genetic Testing
Tags:
Hereditary Cancer ,
Genetic Counseling ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Inherited Mutations ,
23andme
February 22, 2019
FORCE and Other Groups Meet with the Centers for Medicare and Medicaid Services (CMS)
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Hereditary Cancer ,
Hereditary Cancer Research ,
Screening And Prevention ,
PALB2 ,
ATM
February 28, 2018
Five Year Ovarian Cancerversary
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Ovarian Cancer
October 12, 2017
Patients Weigh In On Review of PARP Inhibitors for Treatment of Ovarian Cancer
Posted in:
Laws, Protections And Public Policy ,
Cancer Treatment
Tags:
Ovarian Cancer ,
PARP Inhibitor ,
Patient Advocacy
September 19, 2017
Insurance Coverage for Clinical Trial Participation: Significant Barriers Remain
Posted in:
Laws, Protections And Public Policy ,
Research
Tags:
Clinical Trials ,
Medicare ,
Insurance ,
Insurance Coverage ,
Medicaid
May 11, 2017
Fueling Patient-Focused Health Care
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Hereditary Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
HBOC ,
Personalized Medicine ,
Health Policy ,
Patient Advocacy
April 23, 2017
Reflections on the March for Science
Posted in:
Laws, Protections And Public Policy ,
FORCE And FORCE Impact
Tags:
Research ,
Insurance Coverage ,
March For Science ,
Science
January 26, 2017
Flawed Research and Reporting on the “Angelina Effect” Could Threaten Access to HBOC Care
Posted in:
Laws, Protections And Public Policy ,
XRAY
Tags:
BRCA ,
Hereditary Cancer ,
Breast Cancer ,
Hereditary Cancer Research ,
Genetic Testing ,
Prophylactic Mastectomy ,
BRCA2 ,
Previvor ,
HBOC ,
PALB2 ,
CHEK2 ,
ATM
August 06, 2012
Applying Personalized Medicine to Disease Screening and Prevention
Posted in:
Laws, Protections And Public Policy
Tags:
BRCA ,
Genetics ,
Hereditary Cancer ,
Breast Cancer ,
Cancer Prevention ,
Hereditary Cancer Research ,
Ovarian Cancer ,
Genetic Counseling ,
Genetic Testing ,
Prophylactic Mastectomy ,
BRCA1 ,
BRCA2 ,
Prophylactic Surgery ,
Survivor ,
Ovarian Cancer Early Detection ,
HBOC ,
Prostate Cancer ,
PSA ,
USPSTF ,
Early Detection ,
Personalized Medicine ,
Screening And Prevention
June 01, 2012
13 Facts that Men with Hereditary Cancer Risk Should Know
Posted in:
Laws, Protections And Public Policy ,
Men With Mutations
Tags:
BRCA ,
Genetics ,
Breast Cancer ,
Cancer Prevention ,
Genetic Counseling ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Previvor ,
Survivor ,
Prostate Cancer ,
USPSTF
November 10, 2009
Direct-to-consumer genetic testing: the latest FORCE testimony to SACGHS and FDA feedback
Posted in:
Laws, Protections And Public Policy
Tags:
July 17, 2009
FORCE and Health Care Community Letter in Support of the EARLY Act
Posted in:
Laws, Protections And Public Policy ,
Research
Tags: